Generic Drug Producers Have $45 Billion Opportunity

Generic drug producers have been handed windfall sales over the past decade. According to a new report from Morgan Stanley on the state of the generic drug industry published this week, $160 billion to $170 billion of branded sales have lost patent protection over the last ten years, and generic producers have been quick to take advantage. 

• HHS Secretary Calls for Price Controls on Some Prescription Drugs
• War on Drugs Has Cost America Over $1 Trillion [INFOGRAPHIC]

This trend is expected to continue with roughly $80 billion in branded sales projected to lose patent protection over the next five years. On top of this, Morgan’s proprietary bottom-up analysis of the top 200 branded products in the US identifies additional generic opportunities...